|
|
Singulair - Newsfeeds
-
-
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation. But what many people don't understand is that the steroids that have caused that negative publicity are NOT the kind ...
-
-
faces a big revenue hit from generic competition. Its top seller, Singulair for asthma and allergies, loses patent protection in August 2012. That's after blockbuster blood pressure drugs Cozaar and Hyzaar got generic competition a year ago. Those three ...
-
-
Menstruation and the menstrual cycle are often not well understood by many women, even though it is something they are faced with on a regular basis. On average, the menstrual cycle is 28 days long, but just as all women are different, so are our periods ...
-
-
Asthma symptoms can be similar to the symptoms of other breathing conditions , so it is important to talk to a health care provider to find out what medication is right for you. Your health care provider can also show you how to use your new inhaler ...
-
-
"Our team has achieved amazing milestones over the last year and in these first few months of 2011," said Massage Envy CEO David Humphrey . "We are continuing to expand our reach with the power of a strong brand and a network of talented franchisees who ...
-
-
CINCINNATI , April 18, 2011 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA.ob - News ) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the year ended December 31, 2010 . For the year ended December 31 ...
-
-
faces a big revenue hit from generic competition. Its top seller, Singulair for asthma and allergies, loses patent protection in August 2012. That's after blockbuster blood pressure drugs Cozaar and Hyzaar got generic competition a year ago. Those three ...
-
-
Sales of Merck's biggest product, asthma treatment Singulair, jumped 14 percent to $1.33 billion, helped by strong sales in emerging markets and Japan. But the pill's importance to Merck will fade in coming months, when it faces generic competition in the ...
-
-
are starting to pay off. Merck shares rose 24 cents to $36.01 in morning trading. The maker of Singulair for asthma and allergies and Januvia for diabetes said net income was $1.04 billion, or 34 cents per share, up from $299 million, or 9 cents a share ...
-
-
According to a release issued by the pharmaceutical giant, which has its headquarters in the Whitehouse Station section of Readington, sales of products such as Januvia/Janumet ($1.04 billion) and Singulair ($1.28 billion) in the pharmaceutical sector ...
-
-
Sales of brain tumor drug temodar also declined in the quarter due to generic competition in Europe. Human papillomavirus vaccine gardasil witnessed an 8 percent sales decline.
-
-
Singulair revenue was up 14% year over year, to $1.3 billion (better than expected). Remicare revenue was up 12% year over year, to $753 million (better than expected). Januvia revenue was up 45% year over year, to $739 million (a little lighter than I was expecting).
-
-
The maker of Singulair for asthma and allergies said Q1 earnings rose 11% to 92 cents a share, 8 cents over forecasts. Sales edged up 1% to $11.58 bil, also topping views. It sees 2011 EPS of $3.66-$3.76, the midpoint above analyst consensus of $3.69.
-
-
asthma treatment Singulair, diabetes drug Actos and blood pressure medicine Diovan. "I think we have many strong quarters ahead of us," Mr. Rubino told Reuters in a telephone interview. Pharmacy benefit managers, or PBMs, administer drug benefits for ...
-
-
ST. PAUL, Minn., April 27, 2011 -- /PRNewswire/ -- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ...
-
-
CINCINNATI , April 18, 2011 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the year ended December 31, 2010 . For the year ended December 31, 2010 , the ...
-
-
Low Birth Weight. Infants of low birth weight are at higher risk for lung problems and asthma. Winter Birth. One study suggests that children born in the winter are at greater risk for asthmatic allergies to cockroaches than children born at other times of ...
-
-
Dr. Manuel Ramos-Casals and collaborators reported that there are no therapeutic guidelines for treating Sjogren syndrome based on evidence from clinical trials. They presented a systematic review of the medical literature to help doctors evaluate ...
-
-
It’s worth keeping in mind that sales do not equal popularity. Only three of these drugs (Lipitor, Plavix, and Singulair) rank among the top 25 most popular medicines. Price is often as big a component in making money as volume. It’s also worth noting ...
-
-
Plavix and Singulair both go off patent over the next couple years, ending the age of mass-market medicines completely. The most popular drug, as in previous years, is the combination of hydrocodone and acetaminophen — better known by its old brand name ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
1
2
3
4
5
6
...
Next
|
|
